Business Courier: UC researcher pumped about breakthrough for treatment of heart disease
March 14, 2024
Jack Rubinstein, MD, is the chief medical officer launching TRPV Pharmaceuticals, a company dedicated to advancing a therapeutic approach for cardiovascular disease. Rubinstein is also a UC professor of internal medicine at the UC College of Medicine and a pioneering researcher in the field of cardiovascular diseases.